| scholarly article | Q13442814 |
| P50 | author | Belén Beltrán | Q57943460 |
| Gionata Fiorino | Q37837552 | ||
| Pietro Invernizzi | Q37842572 | ||
| Francesca Bernuzzi | Q38544303 | ||
| Antonino Spinelli | Q40674833 | ||
| Massimo Locati | Q42306569 | ||
| Francesco Marabita | Q42830707 | ||
| P2093 | author name string | S Danese | |
| M Iborra | |||
| C Correale | |||
| P Nos | |||
| S Vetrano | |||
| P2860 | cites work | Identification of unique microRNA signature associated with lupus nephritis | Q21136392 |
| miRBase: integrating microRNA annotation and deep-sequencing data | Q24615914 | ||
| Circulating microRNAs as stable blood-based markers for cancer detection | Q24652098 | ||
| Circulating microRNAs, potential biomarkers for drug-induced liver injury | Q24656209 | ||
| MicroRNAs in inflammatory bowel disease--pathogenesis, diagnostics and therapeutics | Q27025092 | ||
| Micro-RNAs as regulators and possible diagnostic bio-markers in inflammatory bowel disease | Q27027300 | ||
| Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
| Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? | Q27860893 | ||
| Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases | Q28131780 | ||
| Genome-wide maps of circulating miRNA biomarkers for ulcerative colitis | Q28732042 | ||
| miRBase: microRNA Sequences and Annotation | Q29030445 | ||
| Unravelling the pathogenesis of inflammatory bowel disease | Q29547551 | ||
| A novel and universal method for microRNA RT-qPCR data normalization | Q33468633 | ||
| HTqPCR: high-throughput analysis and visualization of quantitative real-time PCR data in R. | Q33508982 | ||
| Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis. | Q53280056 | ||
| Detection of differentially expressed microRNAs in serum of pancreatic ductal adenocarcinoma patients: miR-196a could be a potential marker for poor prognosis. | Q54420834 | ||
| Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. | Q54456800 | ||
| [New knowledge in genetics and inflammatory bowel disease. Are there any practical applications?] | Q82248610 | ||
| The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ | Q84589575 | ||
| Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease | Q33721980 | ||
| miR-16 targets transcriptional corepressor SMRT and modulates NF-kappaB-regulated transactivation of interleukin-8 gene | Q34146384 | ||
| Identification of microRNAs associated with ileal and colonic Crohn's disease | Q34159093 | ||
| MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation | Q34212635 | ||
| Mirna expression profiles identify drivers in colorectal and pancreatic cancers. | Q34221558 | ||
| A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. | Q34240949 | ||
| Circulating MicroRNA in inflammatory bowel disease | Q34258348 | ||
| Peripheral blood MicroRNAs distinguish active ulcerative colitis and Crohnʼs disease | Q34388477 | ||
| miR-140-3p regulation of TNF-α-induced CD38 expression in human airway smooth muscle cells | Q36309177 | ||
| Gene-environment interactions and epigenetic basis of human diseases | Q36730925 | ||
| Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients | Q36955334 | ||
| Interplay of commensal and pathogenic bacteria, genetic mutations, and immunoregulatory defects in the pathogenesis of inflammatory bowel diseases | Q37163426 | ||
| microRNAs and the immune response | Q37178538 | ||
| Circulating microRNA is a biomarker of pediatric Crohn disease. | Q37254246 | ||
| Advances in microRNAs: implications for immunity and inflammatory diseases | Q37295063 | ||
| miR-143 and miR-145 are downregulated in ulcerative colitis: putative regulators of inflammation and protooncogenes | Q37597639 | ||
| Epigenetics and autoimmunity | Q37669513 | ||
| MicroRNAs in autoimmunity and inflammatory bowel disease: crucial regulators in immune response | Q37772260 | ||
| MicroRNAs in inflammatory bowel disease | Q37855716 | ||
| MicroRNAs: Emerging Regulators of Immune-Mediated Diseases | Q37944359 | ||
| Increased expression of microRNA in the inflamed colonic mucosa of patients with active ulcerative colitis | Q38342616 | ||
| Circulating microRNAs in plasma of patients with gastric cancers | Q39986294 | ||
| Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans | Q41412919 | ||
| MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha | Q43467631 | ||
| P433 | issue | 2 | |
| P921 | main subject | inflammation | Q101991 |
| inflammatory bowel diseases | Q917447 | ||
| P304 | page(s) | 250-258 | |
| P577 | publication date | 2013-08-01 | |
| P1433 | published in | Clinical and Experimental Immunology | Q15716708 |
| P1476 | title | Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease | |
| P478 | volume | 173 |
| Q43551236 | Alpha-1 antitrypsin and granulocyte colony-stimulating factor as serum biomarkers of disease severity in ulcerative colitis |
| Q45898977 | Biomarkers in inflammatory bowel diseases: insight into diagnosis, prognosis and treatment. |
| Q36052700 | Biomarkers of Inflammatory Bowel Disease: From Classical Laboratory Tools to Personalized Medicine |
| Q36567001 | Circulating MicroRNA223 is a New Biomarker for Inflammatory Bowel Disease |
| Q38938480 | Circulating microRNAs in Inflammatory Bowel Diseases |
| Q89842586 | Colonic mucosal and serum expression of microRNAs in canine large intestinal inflammatory bowel disease |
| Q35746104 | Comparative MiRNA Expressional Profiles and Molecular Networks in Human Small Bowel Tissues of Necrotizing Enterocolitis and Spontaneous Intestinal Perforation |
| Q33584750 | Comprehensive characterization of serum microRNA profile in response to the emerging avian influenza A (H7N9) virus infection in humans |
| Q27027429 | Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease |
| Q49544593 | Determination of miRNAs from Cancer Stem Cells Using a Low Density Array Platform. |
| Q38304202 | Divergent influence of microRNA-21 deletion on murine colitis phenotypes |
| Q36774145 | Elevated expression of circulating miR876-5p is a specific response to severe EV71 infections |
| Q38896550 | Emerging Biomarkers for the Diagnosis and Monitoring of Inflammatory Bowel Diseases |
| Q98771872 | Fecal MicroRNAs as Potential Biomarkers for Screening and Diagnosis of Intestinal Diseases |
| Q41183433 | Functional Implications of MicroRNAs in Crohn's Disease Revealed by Integrating MicroRNA and Messenger RNA Expression Profiling |
| Q49953206 | Functional role and therapeutic targeting of microRNAs in inflammatory bowel disease |
| Q55119869 | Functional role of microRNA-135a in colitis. |
| Q91725325 | Host-derived fecal microRNAs can indicate gut microbiota healthiness and ability to induce inflammation |
| Q38716163 | Identification of Autophagy-Related Genes and Their Regulatory miRNAs Associated with Celiac Disease in Children. |
| Q46315635 | Identification of Circulating MicroRNA Signatures in Crohn's Disease Using the Nanostring nCounter Technology |
| Q51119596 | Identification of a microRNA landscape targeting the PI3K/Akt signaling pathway in inflammation-induced colorectal carcinogenesis. |
| Q99403342 | Immune and microRNA responses to Helicobacter muridarum infection and indole-3-carbinol during colitis |
| Q42223480 | In Crohn's disease fibrosis-reduced expression of the miR-29 family enhances collagen expression in intestinal fibroblasts |
| Q36088921 | Increased duodenal expression of miR-146a and -155 in pediatric Crohn's disease |
| Q34036608 | Inflammatory bowel disease in pediatric and adolescent patients: a biomolecular and histopathological review |
| Q34784772 | Integrated miRNA and mRNA expression profiling in inflamed colon of patients with ulcerative colitis |
| Q38337742 | Intestinal fibrosis in Crohn's disease: role of microRNAs as fibrogenic modulators, serum biomarkers, and therapeutic targets |
| Q35755835 | Leukocyte-epithelial interactions and mucosal homeostasis |
| Q38217532 | Linking immunity, epigenetics, and cancer in inflammatory bowel disease |
| Q35681510 | MiR-155 modulates the inflammatory phenotype of intestinal myofibroblasts by targeting SOCS1 in ulcerative colitis |
| Q64884469 | Micro-RNAs -106a and -362-3p in Peripheral Blood of Inflammatory Bowel Disease Patients. |
| Q26775937 | MicroRNA in inflammatory bowel disease: Translational research and clinical implication |
| Q52688461 | MicroRNA-mediated dynamic control of mucosal immunity. |
| Q38261018 | MicroRNAs and the regulation of intestinal homeostasis |
| Q38219024 | MicroRNAs: New therapeutic targets for intestinal barrier dysfunction |
| Q38823581 | MicroRNAs: how many in inflammatory bowel disease? |
| Q38492052 | Molecular Analysis of Inflammatory Bowel Disease: Clinically Useful Tools for Diagnosis, Response Prediction, and Monitoring of Targeted Therapy |
| Q38986222 | New Biomarkers for Diagnosing Inflammatory Bowel Disease and Assessing Treatment Outcomes |
| Q38561971 | Noncoding RNAs and chronic inflammation: Micro-managing the fire within. |
| Q30984776 | Normalization of circulating microRNA expression data obtained by quantitative real-time RT-PCR |
| Q38681986 | Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease. |
| Q55068395 | Overexpression of miR-595 and miR-1246 in the sera of patients with active forms of inflammatory bowel disease. |
| Q47258537 | Plasma microRNA Profile Differentiates Crohn's Colitis From Ulcerative Colitis. |
| Q51777094 | Polymorphisms in MIR122, MIR196A2, and MIR124A Genes are Associated with Clinical Phenotypes in Inflammatory Bowel Diseases. |
| Q26773008 | Possible Biomarkers in Blood for Crohn's Disease: Oxidative Stress and MicroRNAs-Current Evidences and Further Aspects to Unravel |
| Q41936990 | Predicted overlapping microRNA regulators of acetylcholine packaging and degradation in neuroinflammation-related disorders. |
| Q47696652 | Rab27-Dependent Exosome Production Inhibits Chronic Inflammation and Enables Acute Responses to Inflammatory Stimuli |
| Q34097859 | Rectal microRNAs are perturbed in pediatric inflammatory bowel disease of the colon. |
| Q40122523 | Role of Altered Expression of miR-146a, miR-155, and miR-122 in Pediatric Patients with Inflammatory Bowel Disease. |
| Q94547424 | Serum Biomarkers for Inflammatory Bowel Disease |
| Q33746984 | Serum miRNA signature diagnoses and discriminates murine colitis subtypes and predicts ulcerative colitis in humans. |
| Q34368789 | Small and Long Regulatory RNAs in the Immune System and Immune Diseases |
| Q35806902 | Sparse Modeling Reveals miRNA Signatures for Diagnostics of Inflammatory Bowel Disease |
| Q38222306 | The emerging role of circulating microRNAs as biomarkers in autoimmune diseases |
| Q38305049 | The emerging role of miRNAs in inflammatory bowel disease: a review |
| Q40980155 | Triptolide exerts protective effects against fibrosis following ileocolonic anastomosis by mechanisms involving the miR-16-1/HSP70 pathway in IL-10-deficient mice |
| Q92814912 | Triptolide inhibits migration and proliferation of fibroblasts from ileocolonic anastomosis of patients with Crohn's disease via regulating the miR‑16‑1/HSP70 pathway |
| Q26768556 | miRNAs as new molecular insights into inflammatory bowel disease: Crucial regulators in autoimmunity and inflammation |
Search more.